Fox Hill Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Fox Hill Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-109,772	Closed	-$3.31M	–	127
2026 Q1	$3.31M	Sell	109,772 -9,426	-8%	-$303K	1.59%	17
2025 Q4	$3.72M	Buy	119,198 +2,851	+2%	+$70.2K	1.73%	17
2025 Q3	$2.35M	Buy	+116,347	New	+$2.04M	1.1%	28

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Fox Hill Wealth Management's TEVA Position: Q2 2026 in Review

Fox Hill Wealth Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026, closing a stake of 109,772 shares — an estimated $3.31M sold.

Fox Hill Wealth Management first reported a position in TEVA in Q3 2025 and held it in 3 quarters. The position peaked at $3.72M in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Fox Hill Wealth Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2026 after selling out during the quarter.
Fox Hill Wealth Management sold 109,772 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $3.31M.
Fox Hill Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2025 and held it in 3 quarters.
Fox Hill Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $3.72M in Q4 2025.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Fox Hill Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.